aldosterone has been researched along with Hyperparathyroidism, Secondary in 8 studies
Hyperparathyroidism, Secondary: Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The appearance of SHPT in aldosteronism, induced by fallen plasma [Ca]o, leads to PTH-mediated Ca overloading of PBMC and their increased production of H2O2." | 5.33 | Preventing oxidative stress in rats with aldosteronism by calcitriol and dietary calcium and magnesium supplements. ( Ahokas, RA; Bhattacharya, SK; Gerling, IC; Goodwin, KD; Sun, Y; Weber, KT, 2006) |
| " Hyperaldosteronism due to klotho deficiency results in vascular calcification, which can be mitigated by spironolactone treatment." | 4.90 | Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. ( Fahrleitner-Pammer, A; Gaksch, M; Grübler, M; Kienreich, K; Kraigher-Krainer, E; März, W; Mrak, P; Pieske, B; Pilz, S; Ritz, E; Rus-Machan, J; Tomaschitz, A; Toplak, H; Verheyen, N, 2014) |
| "Fibrosis is a fundamental component of the adverse structural remodeling of myocardium present in the failing heart." | 2.47 | Cellular and molecular pathways to myocardial necrosis and replacement fibrosis. ( Ahokas, RA; Bhattacharya, SK; Gandhi, MS; Gerling, IC; Kamalov, G; Shahbaz, AU; Sun, Y; Weber, KT, 2011) |
| "Aldosterone levels before treatment were positively correlated with serum PTH levels." | 1.62 | Hyperparathyroidism in patients with overt and mild primary aldosteronism. ( Glycofridi, S; Gravvanis, C; Markou, Α; Papanastasiou, L; Piaditis, G; Theodora, K; Tyfoxylou, E; Voulgaris, N, 2021) |
| "The appearance of SHPT in aldosteronism, induced by fallen plasma [Ca]o, leads to PTH-mediated Ca overloading of PBMC and their increased production of H2O2." | 1.33 | Preventing oxidative stress in rats with aldosteronism by calcitriol and dietary calcium and magnesium supplements. ( Ahokas, RA; Bhattacharya, SK; Gerling, IC; Goodwin, KD; Sun, Y; Weber, KT, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Gravvanis, C | 1 |
| Papanastasiou, L | 1 |
| Glycofridi, S | 1 |
| Voulgaris, N | 1 |
| Tyfoxylou, E | 1 |
| Theodora, K | 1 |
| Piaditis, G | 1 |
| Markou, Α | 1 |
| Ceccoli, L | 1 |
| Ronconi, V | 1 |
| Giovannini, L | 1 |
| Marcheggiani, M | 1 |
| Turchi, F | 1 |
| Boscaro, M | 1 |
| Giacchetti, G | 1 |
| Tomaschitz, A | 1 |
| Ritz, E | 1 |
| Pieske, B | 1 |
| Rus-Machan, J | 1 |
| Kienreich, K | 1 |
| Verheyen, N | 1 |
| Gaksch, M | 1 |
| Grübler, M | 1 |
| Fahrleitner-Pammer, A | 1 |
| Mrak, P | 1 |
| Toplak, H | 1 |
| Kraigher-Krainer, E | 1 |
| März, W | 1 |
| Pilz, S | 1 |
| Gandhi, MS | 1 |
| Kamalov, G | 1 |
| Shahbaz, AU | 1 |
| Bhattacharya, SK | 3 |
| Ahokas, RA | 3 |
| Sun, Y | 3 |
| Gerling, IC | 3 |
| Weber, KT | 3 |
| Goodwin, KD | 1 |
| Selektor, Y | 1 |
| Clark, I | 1 |
| Rocher, LL | 1 |
| Tannen, RL | 1 |
3 reviews available for aldosterone and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
Topics: Adrenalectomy; Aldosterone; Animals; Bone Density; Bone Diseases; Calcium; Cardiovascular Diseases; | 2014 |
Cellular and molecular pathways to myocardial necrosis and replacement fibrosis.
Topics: Aldosterone; Animals; Disease Models, Animal; Fibrosis; Heart Failure; Humans; Hypercalciuria; Hyper | 2011 |
The clinical spectrum of renal tubular acidosis.
Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Ammonium Chloride; Animals; Bicarbonates; Bone Diseases | 1986 |
5 other studies available for aldosterone and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
Hyperparathyroidism in patients with overt and mild primary aldosteronism.
Topics: Aldosterone; Calcium; Humans; Hyperaldosteronism; Hyperparathyroidism, Secondary; Parathyroid Hormon | 2021 |
Bone health and aldosterone excess.
Topics: Absorptiometry, Photon; Adult; Aged; Aldosterone; Bone Density; Calcium; Essential Hypertension; Fem | 2013 |
Preventing oxidative stress in rats with aldosteronism by calcitriol and dietary calcium and magnesium supplements.
Topics: Aldosterone; Animals; Calcitriol; Calcium; Cytoplasm; Dietary Supplements; Heart Failure; Humans; Hy | 2006 |
Cinacalcet and the prevention of secondary hyperparathyroidism in rats with aldosteronism.
Topics: Aldosterone; alpha 1-Antitrypsin; Animals; Calcium; Cinacalcet; Hydrogen Peroxide; Hyperaldosteronis | 2008 |
Amelioration of nutritional secondary hyperparathyroidism in rats by adrenalectomy.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Animals; Calcium; Hyperparathyroidism, Secondary; Magnes | 1978 |